UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
Repare Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Québec | Not Applicable | |
(State of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |
7210 Frederick-Banting, Suite 100 St-Laurent, Québec, Canada |
H4S 2A1 | |
(Address of principal executive offices) | (Zip code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class |
Name of exchange on which | |
Common Shares, no par value per share | The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement number to which the form relates: 333-238822
Securities to be registered pursuant to Section 12(g) of the Act: None
Item 1. | Description of Registrants Securities to be Registered. |
Repare Therapeutics Inc. (the Registrant) hereby incorporates by reference the description of its common shares, no par value per share, to be registered hereunder contained under the heading Description of Share Capital in the Registrants Registration Statement on Form S-1 (File No. 333-238822), as originally filed with the Securities and Exchange Commission (the Commission) on May 29, 2020, as subsequently amended (the Registration Statement), and in the related prospectus included in the Registration Statement to be filed separately by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.
Item 2. | Exhibits. |
Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
REPARE THERAPEUTICS INC. | ||||
Date: June 16, 2020 |
By: |
/s/ Lloyd M. Segal | ||
Lloyd M. Segal | ||||
President and Chief Executive Officer |